Share of pharmaceutical revenue of Recordati in 2023, by segment

In 2023, pharmaceutical revenues by Italian company Recordati were distributed into two major segments: specialty/primary care and rare diseases. During this period, most of revenues were generated by the specialty and primary care division, with 65.7 percent, while rare diseases treatments generated 34.3 percent. This statistic displays the distribution of Recordati's pharmaceutical revenues in 2023, by segment.